Full Breakdown
New VA Rule Alters Disability Compensation Ratings for Veterans
2/18/2026, 9:01:21 PM
Overview of the New Rule
On February 17, 2026, the Department of Veterans Affairs (VA) implemented an interim final rule titled “Evaluative Rating: Impact of Medication,” which changes how disability compensation is assessed for veterans. Under this new regulation, disability ratings will be determined based on how well veterans function while on medication, rather than the severity of their underlying impairments. This rule applies to both new claims and the reevaluation of existing disabilities.
Background and Context
The new rule was introduced following a 2025 ruling by the U.S. Court of Appeals for Veterans Claims in *Ingram v. Collins*, which mandated that the VA disregard the ameliorating effects of medication when determining disability levels for musculoskeletal conditions. The VA criticized this court ruling as an "erroneous interpretation" of existing regulations, arguing that it could lead to increased administrative costs and delays in benefit delivery.
Key Concerns from Veterans and Advocates
Veterans and advocacy groups have expressed significant concern regarding the potential implications of this rule. Critics argue that it could lead to lower disability ratings and reduced compensation for many veterans. Jason Cameron, a Marine Corps veteran, described the rule as an "erosion of benefits," while Charles Garbarino, a retired Army colonel, warned that veterans might stop taking their medications to avoid losing compensation. Michael Figlioli, the national service director for Veterans of Foreign Wars, emphasized that this rule represents a significant change in how disability claims are evaluated, contrary to the VA's assertion that it formalizes longstanding practices.
Official Statements & Responses
VA spokesman Pete Kasperowicz stated that the new regulation simply formalizes a practice that has been in place since 1958, asserting that the VA has always considered the impact of medications on disability ratings. However, many veterans' organizations, including Disabled American Veterans, have voiced alarm over the expedited process through which the rule was enacted, arguing that it effectively excluded veterans from providing meaningful input.
Criticism & Opposition
The rule has faced backlash for its implementation process, which critics describe as closed and lacking transparency. Michael Embrich, a Navy veteran, criticized the VA for attempting to push through the rule without adequate public comment, stating that the public comment link on the federal register was non-functional. This has raised concerns about the potential for legal challenges in the future, as veterans fear that the damage from the rule may already be done by the time any court adjudication occurs.
What's Next
The VA has opened a public comment period that will run until April 20, 2026, allowing veterans and stakeholders to voice their opinions on the new rule. However, the immediate implementation of the rule means that its effects on veterans' disability ratings and compensation could be felt before any revisions are made based on public feedback.
Verbatim Quotes
- “This is an erosion of benefits,” — Jason Cameron, Marine Corps Veteran
- “You’re potentially going to force a veteran whose condition is serious enough to be put on antidepressants or other medications, and now you’re going to rate them at the level that the medication provides [them] relief,” — Michael Figlioli, National Service Director for Veterans of Foreign Wars
- “It’s incredibly messy and politically ugly, and they’re just gonna try to shove a rule change down our throat,” — Michael Embrich, Navy Veteran
The new rule's implementation marks a significant shift in the VA's approach to disability compensation, raising critical questions about its impact on veterans' health and financial stability.
